Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2

SARS-CoV-2 variants may threaten the effectiveness of vaccines and antivirals to mitigate serious COVID-19 disease. This is of most concern in clinically vulnerable groups such as older adults. We analysed 72 sera samples from 37 individuals, aged 70–89 years, vaccinated with two doses of BNT162b2 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Joseph, Thakur, Nazia, Peacock, Thomas P., Bialy, Dagmara, Elrefaey, Ahmed M. E., Bogaardt, Carlijn, Horton, Daniel L., Ho, Sammy, Kankeyan, Thivya, Carr, Christine, Hoschler, Katja, Barclay, Wendy S., Amirthalingam, Gayatri, Brown, Kevin E., Charleston, Bryan, Bailey, Dalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352594/
https://www.ncbi.nlm.nih.gov/pubmed/35836002
http://dx.doi.org/10.1038/s41564-022-01163-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352594/
https://www.ncbi.nlm.nih.gov/pubmed/35836002
http://dx.doi.org/10.1038/s41564-022-01163-3

Ejemplares similares